HTG EdgeSeq technology offers a competitive alternative to RNA-Seq with equivalent performance and distinct advantages.
Read how the HTG EdgeSeq technology is a competitive alternative to RNA-Seq
- Categories
- White Papers
Categories
Filter by Topics
ALK cMET FFPE HER2 HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq PATH Assay Lung MET Mutations NTRK1 Rearrangements RET ROS12020
2018
Detecting clinically relevant ALK rearrangements: Comparing the HTG EdgeSeq ALKPlus Assay EU (CE-IVD)to a commercially available ALK FISH assay
Numerous mutations have been shown to drive oncogenesis in non-small cell lung cancer (NSCLC). Measuring these events with conventional methods is difficult given the small amount of material typically collected in the standard needle core biopsy or similar tissue collection method.
- Categories
- White Papers
2017
A Research Use Only Content Guide for ALK, ROS1, RET, NTRK1, HER2 and cMET Data Generated from the HTG EdgeSeq ALKPlus Assay EU
A Research Use Only Content Guide for ALK, ROS1, RET, NTRK1, HER2 and cMET Data Generated from the HTG EdgeSeq ALKPlus Assay EU
- Categories
- White Papers
Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU
Detection of clinically relevant gene fusions with the HTG EdgeSeq ALKPlus Assay EU
- Categories
- White Papers
Post-Sequencing Quality Control Metric for the HTG EdgeSeq PATH Assay
HTG EdgeSeq PATH Assay QC white paper
- Categories
- White Papers
- Topics:
- HTG EdgeSeq PATH Assay
Complement IHC Studies with the HTG EdgeSeq PATH Assay
HTG white paper: Complement IHC Studies with the HTG EdgeSeq PATH Assay. 2017
- Categories
- White Papers
- Topics:
- HTG EdgeSeq PATH Assay
Page last updated September 21, 2020